Shalin Jani, M.S., is a seasoned executive with over 20 years of expertise in the pharmaceutical industry. Before stepping into the CEO role, Shalin served as COO and Head of Regulatory Affairs at Solaris Pharma, where he oversaw a broad range of critical functions, including Portfolio Strategy, Business Development & Licensing, Sales and Marketing, Procurement, CMO Selection/Alliance Management, Budgeting and Forecasting, Commercialization (from scale-up to product launch), and Regulatory Affairs.

 

With extensive experience in Operations, R&D, Clinical Development, and Regulatory Affairs, Shalin has contributed to the generic, 505(b)(1), and 505(b)(2) drug spaces at prominent companies such as Teva, Sandoz, Actavis, and Pfizer.

 

Shalin holds a Master’s degree in Cell and Developmental Biology from UMDNJ/Rutgers University and a Bachelor’s degree in Molecular Biology and Biochemistry from Rutgers University. His strategic vision and industry insights continue to propel Solaris Pharma’s success in a dynamic pharmaceutical landscape.